Research progress in treatment of symptomatic non-acute middle cerebra artery arteriosclerosis occlusion
10.3760/cma.j.cn101721-20240805-00246
- VernacularTitle:症状性非急性期大脑中动脉粥样硬化性闭塞治疗的研究进展
- Author:
Chenyang HUANG
1
;
Tingyu LIU
;
Qingfeng ZHU
Author Information
1. 山西医科大学第二临床医学院，太原 030001
- Publication Type:Journal Article
- Keywords:
Non-acute middle cerebraartery arteriosclerosis occlusion;
Intervention;
Extracranial-intracranial bypass surgery
- From:
Clinical Medicine of China
2025;41(2):155-160
- CountryChina
- Language:Chinese
-
Abstract:
In the non-acute phase, when the collateral circulation is poorly compensated due to atherosclerotic occlusion of the middle cerebral artery, it can lead to significant neurological dysfunction and a higher recurrence rate of stroke. Traditional treatments primarily involve managing risk factors and administering symptomatic pharmacotherapy, yet the outcomes are often unsatisfactory. In recent years, with the development of endovascular interventional techniques and interventional materials, microsurgical anastomosis, techniques, and the present of distal ischemic modulation, the treatment of symptomatic arteriosclerosis occlusion of the non-acute middle cerebral artery is attracting more and more attention in the field. This article reviews the progress of the treatment of symptomatic arteriosclerosis occlusion of the non-acute middle cerebral artery. For the surgical treatment of symptomatic non-acute middle cerebral artery atherosclerosis occlusion (SNMCAO) in non-acute phase, the superior temporal artery middle cerebral artery (STA-MCA) low flow bypass and intravascular interventional recanalization have their own advantages. For patients with short expected occlusion time, short occlusion segment, straight blood vessels, and good distal vascular bed, they may be more inclined to undergo endovascular recanalization treatment, otherwise they may choose STA-MCA low flow bypass surgery. Regardless of which treatment method is chosen, precise individualized evaluation must be conducted before surgery to select an individualized surgical approach that can maximize the benefits for patients with SNMCAO.
